We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ORGS market cap is 18.16M. The company's latest EPS is USD -1.7367 and P/E is -0.33.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.01M | 13.62M | 7.04M | 6.98M | 141k |
| Operating Income | -281k | -607k | -3.21M | -3.33M | -8.93M |
| Net Income | -1.36M | -4.1M | -4.19M | -4.13M | -9.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 33.48M | 7.76M | 37.78M | 36.03M | 530k |
| Operating Income | -24.6M | -95.68M | -14.52M | -8.6M | -52.94M |
| Net Income | -24.12M | -94.6M | -18.05M | -14.89M | -55.36M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 70.69M | 90.93M | 93.27M | 54.77M | 30.92M |
| Total Liabilities | 40.44M | 31.65M | 33.96M | 30.8M | 58.47M |
| Total Equity | 30.25M | 29.07M | 29M | 23.97M | -27.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.5M | 77.68M | 59.84M | 90.93M | 14.55M |
| Total Liabilities | 55.46M | 24.96M | 21.21M | 31.65M | 35.54M |
| Total Equity | 6.08M | 52.73M | 38.63M | 29.07M | -20.98M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.16M | -24.92M | -7.24M | -13.15M | -4.44M |
| Investing | -7.46M | -14.13M | -1.31M | -2.8M | -68k |
| Financing | 20.1M | 39.58M | 5.91M | 10.8M | 3.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.22M | -78.05M | -26.87M | -24.92M | -14.84M |
| Investing | -13.78M | 105.61M | -12.38M | -14.13M | -3.71M |
| Financing | 24.1M | 5.88M | -106k | 39.58M | 13.62M |
| Market Cap | 18.16M |
| Price to Earnings Ratio | -0.33 |
| Price to Sales Ratio | 34.34 |
| Price to Cash Ratio | 21.67 |
| Price to Book Ratio | -0.87 |
| Dividend Yield | - |
| Shares Outstanding | 31.88M |
| Average Volume (1 week) | 54.84k |
| Average Volume (1 Month) | 39.08k |
| 52 Week Change | -56.50% |
| 52 Week High | 1.50 |
| 52 Week Low | 0.25 |
| Spread (Intraday) | 0.31 (37.96%) |
| Company Name | Orgenesis Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://orgenesis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
